Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models
Summary: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against...
Saved in:
Main Authors: | Daniel J. Sheward, Marco Mandolesi, Egon Urgard, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Alec Pankow, Natalie L. Smith, Xaquin Castro Dopico, Gerald M. McInerney, Jonathan M. Coquet, Gunilla B. Karlsson Hedestam, Ben Murrell |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f6fbb94e1aa445b28a40632a0756d791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
by: Leo Hanke, et al.
Published: (2020) -
Investigating the Concerns of First-Time Distance Education Instructors
by: Halil Kayaduman, et al.
Published: (2019) -
Model-Based Prediction of an Effective Adhesion Parameter Guiding Multi-Type Cell Segregation
by: Philipp Rossbach, et al.
Published: (2021) -
Examining the Relative Influence of Risk and Control on Intention to Adopt Risky Technologies
by: Gupta,Sumeet, et al.
Published: (2010) -
Mapping Population Distribution Based on XGBoost Using Multisource Data
by: Xin Zhao, et al.
Published: (2021)